Effect of depression and diabetes mellitus on the risk for dementia: A national population-based cohort study

JAMA Psychiatry

Volumn 72, Issue 6, 2015, Pages 612-619

  Katon, Wayne ^a   Pedersen, Henrik Sondergaard ^b   Ribe, Anette Riisgaard ^b   Fenger Grøn, Morten ^b   Davydow, Dimitry ^a   Waldorff, Frans Boch ^c   Vestergaard, Mogens ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; MEMANTINE;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DANISH CITIZEN; DEMENTIA; DEPRESSION; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PSYCHIATRIST; COHORT ANALYSIS; DENMARK; DIABETES MELLITUS, TYPE 2; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK FACTOR;

AGED; COHORT STUDIES; COMORBIDITY; DEMENTIA; DENMARK; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS;

EID: 84931086725     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2015.0082     Document Type: Article

References (47)

1. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29. doi:10.1186/1478-7954-8-29.
2. Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012;21(3):169-184.
3. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006;23(11):1165-1173.
4. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31(12):2383-2390.
5. Lin EH, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004;27(9):2154-2160.
6. Vreeburg SA, Hoogendijk WJ, Van Pelt J, et al. Major depressive disorder and hypothalamicpituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry. 2009;66(6):617-626.
7. Kemp AH, Quintana DS, Gray MA, Felmingham KL, Brown K, Gatt JM. Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry. 2010;67(11):1067-1074.
8. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446-457.
9. Lin EH, Rutter CM, Katon W, et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care. 2010;33(2):264-269.
10. Lu FP, Lin KP, Kuo HK. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One. 2009;4(1):e4144. doi:10.1371/journal.pone.0004144.
11. Jorm AF. Is depression a risk factor for dementia or cognitive decline? a review. Gerontology. 2000;46(4):219-227.
12. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry. 2006;63(5):530-538.
13. Katon WJ, Lin EH, Williams LH, et al. Comorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study. J Gen Intern Med. 2010;25(5):423-429.
14. Katon W, Lyles CR, Parker MM, Karter AJ, Huang ES, Whitmer RA. Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study. Arch Gen Psychiatry. 2012;69(4):410-417.
15. Exalto LG, Biessels GJ, Karter AJ, et al. Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol. 2013;1(3):183-190.
16. Sullivan MD, Katon WJ, Lovato LC, et al. Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial. JAMA Psychiatry. 2013;70(10):1041-1047.
17. Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011;7(3):137-152.
18. May AL, Kuklina EV, Yoon PW. Prevalence of cardiovascular disease risk factors among US adolescents, 1999-2008. Pediatrics. 2012;129(6):1035-1041.
19. Song SH, Hardisty CA. Early onset type 2 diabetes mellitus: a harbinger for complications in later years-clinical observation from a secondary care cohort. QJM. 2009;102(11):799-806.
20. Chan JC, Lau ES, Luk AO, et al. Premature mortality and comorbidities in young-onset diabetes: a 7-year prospective analysis. Am J Med. 2014;127(7):616-624.
21. Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39(7) (suppl):22-25.
22. World Health Organization. Manual of the International Classification of Diseases, Eighth Revision (ICD-8). Geneva, Switzerland: World Health Organization; 1967.
23. World Health Organization. International Statistical Classification of Diseases, 10th Revision (ICD-10). Geneva, Switzerland: World Health Organization; 1992.
24. Phung TK, Waltoft BL, Kessing LV, Mortensen PB, Waldemar G. Time trend in diagnosing dementia in secondary care. Dement Geriatr Cogn Disord. 2010;29(2):146-153.
25. Mors O, Perto GP, Mortensen PB. The Danish Psychiatric Central Research Register. Scand J Public Health. 2011;39(7) (suppl):54-57.
26. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7) (suppl):38-41.
27. Skrbo A, Zulic I, Hadzic S, Gaon ID. Anatomic-therapeutic-chemical classification of drugs [in Croatian]. Med Arh. 1999;53(3) (suppl 3):57-60.
28. Carstensen B, Kristensen JK, Marcussen MM, Borch-Johnsen K. The National Diabetes Register. Scand J Public Health. 2011;39(7) (suppl):58-61.
29. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(7) (suppl):30-33.
30. Phung TK, Andersen BB, Høgh P, Kessing LV, Mortensen PB, Waldemar G. Validity of dementia diagnoses in the Danish hospital registers. Dement Geriatr Cogn Disord. 2007;24(3):220-228.
31. Salem LC, Andersen BB, Nielsen TR, et al. Overdiagnosis of dementia in young patients: a nationwide register-based study. Dement Geriatr Cogn Disord. 2012;34(5-6):292-299.
32. De Toledo Ferraz Alves TC, Ferreira LK, Wajngarten M, Busatto GF. Cardiac disorders as risk factors for Alzheimer's disease. J Alzheimers Dis. 2010;20(3):749-763.
33. Butters MA, Young JB, Lopez O, et al. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci. 2008;10(3):345-357.
34. Feldman HH, Jacova C, Robillard A, et al. Diagnosis and treatment of dementia, 2: diagnosis. CMAJ. 2008;178(7):825-836.
35. Andersson T, Alfredsson L, Källberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20(7):575-579.
36. Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF III. Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013;202(5):329-335.
37. Ismail K, Winkley K, Stahl D, Chalder T, Edmonds M. A cohort study of people with diabetes and their first foot ulcer: the role of depression on mortality. Diabetes Care. 2007;30(6):1473-1479.
38. Katon W, Von Korff M, Ciechanowski P, et al. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care. 2004;27(4):914-920.
39. Ritchie K, Carrière I, Ritchie CW, Berr C, Artero S, Ancelin ML. Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ. 2010;341:c3885. doi:10.1136/bmj.c3885.
40. Katon WJ, Von Korff M, Lin EH, et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry. 2004;61(10):1042-1049.
41. Williams JW Jr, Katon W, Lin EH, et al; IMPACT Investigators. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med. 2004;140(12):1015-1024.
42. Katon WJ, Lin EH, Von Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611-2620.
43. ∗D clinical trial. Gen Hosp Psychiatry. 2005;27(2):87-96.
44. Cooper-Patrick L, Crum RM, Ford DE. Characteristics of patients with major depression who received care in general medical and specialty mental health settings. Med Care. 1994;32(1):15-24.
45. Bet PM, Hugtenburg JG, Penninx BW, Balkom Av, Nolen WA, Hoogendijk WJ. Treatment inadequacy in primary and specialized care patients with depressive and/or anxiety disorders. Psychiatry Res. 2013;210(2):594-600.
46. Linn RT, Wolf PA, Bachman DL, et al. The "preclinical phase" of probable Alzheimer's disease: a 13-year prospective study of the Framingham cohort. Arch Neurol. 1995;52(5):485-490.
47. Pratley RE. The early treatment of type 2 diabetes. Am J Med. 2013;126 (9) \ (suppl 1):S2-S9.